Skip to main content
Clinical Trials/ACTRN12609000332224
ACTRN12609000332224Completed未知

In people with chronic obstructive pulmonary disease (COPD), does the use of a wheeled walker in the home and community change daily physical activity?

Dr. Sue Jenkins0 sites30 target enrollmentStarted: May 22, 2009Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
30

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Open (masking not used)

Eligibility Criteria

Ages
o limit to o limit (—)
Sex
All

Inclusion Criteria

  • Diagnosis of COPD
  • Six-minute walk distance < 450 m prior to pulmonary rehabilitation
  • Deemed approp for a wheeled walker by a physiotherapist

Exclusion Criteria

  • use of a wheeled walker for more than 2 weeks prior to commencing pulmonary rehabilitation
  • any co-morbid condition that limits mobility

Investigators

Sponsor
Dr. Sue Jenkins

Similar Trials

Completed
Not Applicable
Can changing the way people with chronic lung disease think about breathlessness improve and sustain health outcomes?breathlessnessRespiratory - Chronic obstructive pulmonary diseasePublic Health - Health promotion/educationPhysical Medicine / Rehabilitation - Other physical medicine / rehabilitation
ACTRN12611000292976niversity of South Australia120
Recruiting
Not Applicable
Electronic Snapshot for Outpatient Management of Chronic Obstructive Pulmonary Disease (COPD)Chronic obstructive pulmonary diseaseRespiratory - Chronic obstructive pulmonary diseasePublic Health - Health service research
ACTRN12614000296639The Prince Charles Hospital200
Completed
Not Applicable
sing behaviour change interventions to reduce sedentary time in people with chronic obstructive pulmonary diseaseChronic obstructive pulmonary diseaseRespiratory - Chronic obstructive pulmonary disease
ACTRN12619000856112Curtin University10
Not yet recruiting
Phase 3
Combined corticosteroid and long-acting beta-agonist versus corticosteroid for moderate/severe chronic obstructive pulmonary disease. A double blind, randomized, multicenter, phase III study.COPD (Chronic obstructive pulmonary disease)Respiratory - Chronic obstructive pulmonary disease
ACTRN12609000850279Aché Laboratories136
Not yet recruiting
Not Applicable
Prevalence of chronic obstructive pulmonary disease and asthma in the community of Pathumthani, ThailandAsthmaCOPDCOPDPrevalenceLung functionAsthma
TCTR20230711002Thailand Science Research and Innovation1,080